The Council for Innovation Promotion (C4IP) praises @RepZoeLofgren (D-CA) for introducing the Foreign Anti-Digital Piracy Act (FADPA) to protect American artists' and creators' copyrighted works from foreign thieves. Read our full statement on the act:

January was a productive month for C4IP! In January, we focused on key policy priorities for 2025, which include PERA, the PREVAIL Act, and the RESTORE Patent Rights Act To learn more, check out our coalition updates blog 👇

"Global piracy costs America up to 560,000 jobs and robs our content production industries of up to $71 billion in revenue each year. Reducing foreign piracy would bolster the U.S. economy and strengthen our entertainment industry." - C4IP Executive Director Frank Cullen Read the full statement at the link below:

DYK that China is currently outcompeting the U.S. in 57 of 64 cutting-edge technology fields? In the early 2000s, China was ahead in just three technologies tracked by @ASPI_org. For more information about this critical technology tracker, visit the link below 👇

❌ Myth: The @USPTO has a "persistent problem" with "issuing a countless number [of] dubious patents each year." ✔️ Fact: The percentage of invalid patents granted is very low -- in the single digits. For more on patent myths, take a look at the fact-check section of our latest newsletter:

RT @IP_IdeasMatter: Former @uspto and @Council4IP Chairman Andrei Iancu warns that too much AI regulation could hurt U.S. innovation more t…

📰 ICYMI: @ColoradoCollege professor of economics Kristina Acri published a piece on a SCOTUS decision that has harmed American innovation by undermining small companies and entrepreneurs. Take a look at our blog unpacking the op-ed:

📜 Why does C4IP support the PREVAIL Act? This bipartisan, landmark bill would reform the PTAB to eliminate duplicative proceedings -- which unfairly benefit corporate giants accused of infringement -- and protect inventors' right to "quiet title" for their patents. Learn more:

"The EU should take robust measures to ensure that inventors and creators remain incentivised to reinvest in further creation and innovation. Doing so will foster an environment where innovation thrives while simultaneously safeguarding the interests and rights of those who drive progress." Check out this recent letter calling on EU policymakers to support innovation! 🔗

"Section 101, the … patent code that defines our 21st-century patent system in the United States, was written in the 18th century by our founders… Congress has not legislated in that area since 1793." 🎙️ Hear more from C4IP Co-Chair and fmr. USPTO Director Andrei Iancu:

The latest edition of our IP Policy Roundup newsletter was just released! In this edition, you'll find: 📅 A breakdown of C4IP's key policy priorities for 2025 ✅ A fact-check on the myths surrounding "bad patents" ✨ A spotlight on Warren S. Johnson, inventor of the first temperature regulation system Read it here:

RT @DrewForNevada: @IMAKglobal Please familiarize yourself with Title 35 of the U.S. Code, @IMAKglobal. Patents are only granted for new, u…

"...no artist should have to compete with an AI clone of their own voice or vision. To address these challenges, Congress is considering the NO FAKES Act, which aims to protect individuals from unauthorized AI manipulations like 'deepfakes' while safeguarding legitimate uses." C4IP Co-Chairs and fmr. @USPTO Directors Andrei Iancu and David Kappos Read more:

Patents and innovation go hand in hand 🤝 America's status as the world's strongest economy, our role in pioneering new technologies, and our continued national security all rely on patent laws that promote innovation by guaranteeing inventors an exclusive right to their creations. Learn more:

RT @DefendInventors: Former @USPTO Director and current @Council4IP Chairman Andrei Iancu calls out the value of permanent injunctions and…

Check out this @Forbes article highlighting C4IP's statement on the recently introduced Foreign Anti-Digital Piracy Act: "'Providing courts with [the authority to block foreign pirate sites] would deliver significant benefits for America's economy,' commented Frank Cullen, executive director of the Council for Innovation Promotion." 🔗

Anti-patent activists have repeatedly made unfounded and highly questionable assertions that pharmaceutical companies unfairly "extend" patents in order to prolong market exclusivity and prevent generic competition. Not only is it impossible to extend a patent in this way, but an analysis of how the patent system is used in this industry shows that biopharma companies usually do not get even close to the length of a full patent term -- 20 years -- before they face generic competition. Learn more about patent myths:

"U.S. intellectual property laws are so unclear that even experienced attorneys can't figure out which inventions are eligible for patent protection." Continue reading to find out more about this critical issue and how lawmakers can solve it 👇

🏛️ A series of SCOTUS decisions have created major uncertainty around U.S. patent eligibility for cutting-edge inventions, including diagnostic testing and AI. PERA would restore patent eligibility to these crucial categories of inventions. Learn more:

Check out C4IP Board Mbr. & Fmr. Fed. Judge Kathleen O'Malley's latest on the @BayhDole Act: "Federal agencies have neither the expertise nor the economic resources to commercialise government-funded discoveries. That inability is precisely why Congress passed the bipartisan Bayh-Dole Act in 1980." 🔗